20250186603. Anti-gd2 Antibodies, Immunoc (Merck Patent)
ANTI-GD2 ANTIBODIES, IMMUNOCONJUGATES AND THERAPEUTIC USES THEREOF
Abstract: the invention provides antibodies which bind human gd2 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. the invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. the invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.
Inventor(s): Sean D. MCKENNA, Alec GROSS, Jianguo MA, Julia DOTTERWEICH, Nicolas RASCHE, Min SHAN, Christiane AMENDT, Jan ANDERL, Willem SLOOT
CPC Classification: A61K47/68037 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates})
Search for rejections for patent application number 20250186603
- Patent Applications
- Merck Patent GmbH
- CPC A61K47/68037
- Sean D. MCKENNA of Duxbury MA US
- Alec GROSS of Newton MA US
- Jianguo MA of Newton MA US
- Julia DOTTERWEICH of Darmstadt DE
- Nicolas RASCHE of Darmstadt DE
- Min SHAN of Darmstadt DE
- Christiane AMENDT of Muehltal DE
- Jan ANDERL of Lautertal DE
- Willem SLOOT of Heesch NL